As India prepares for mass vaccination against Covid once approvals are obtained, states with more people in the age group 50 and over and with comorbidities like diabetes and hypertension are expected to get larger allocations (plus, of course , frontline healthcare workers, essential personnel, and police and defense personnel). …
Read More »Frontline staff, over 50, youth at risk
Written by Kaunain Sheriff M | New Delhi | Updated: December 9, 2020 10:03:07 am At the Serum Institute of India on Monday. (Photo: Reuters) One crore of health workers, two crore of frontline workers, including the police and armed forces, and around 27 crore of people over 50 and …
Read More »3 Covid-19 Vaccine Developers Seek Emergency Use Approval In India
Written by Kaunain Sheriff M, Amitabh Sinha | New Delhi, Pune | Updated: December 9, 2020 10:02:09 am Vials of Covishield, the Indian version of the AstraZeneca-Oxford vaccine, at the Serum Institute of India in Pune, India. (Reuters photo) Three vaccine developers have submitted applications to the Central Drug Standards …
Read More »Bharat Biotech’s COVID-19 ‘Covaxin’ Vaccine Begins Phase 3 Clinical Trial in Kolkata
The COVID-19 candidate vaccine ‘Covaxin’, in phase 3 clinical trials, is being developed by Bharat Biotech Calcutta: West Bengal Governor Jagdeep Dhankhar today inaugurated the launch of Covaxin’s phase 3 regulatory trial at ICMR-NICED in Kolkata, praising the country’s leadership in “effectively addressing” the COVID-19 pandemic. Dhankhar said the NICED …
Read More »Serum Institute will request emergency authorization in the next 2 weeks
The Serum Institute of India will apply for emergency clearance for the COVID-19 vaccine in the next two weeks, Executive Director Adar Poonawalla said on Saturday. The Pune-based pharmaceutical company has partnered with global pharmaceutical giant AstraZeneca to produce the COVID-19 vaccine for the University of Oxford for low- and …
Read More »The Optimal Storage Temperature for Pioneering Covid-19 Vaccines
By: Desk Explained | New Delhi | Updated: November 24, 2020 5:27:30 pm The storage of a vaccine depends on the temperature at which it must be kept so that its potency remains intact. There are several vaccines for Covid-19 in the works. As some enter the final stages of …
Read More »How effective are the main Covid-19 vaccines, when will they be available?
Written by Abhishek De, edited by Explained Desk | New Delhi | Updated: November 20, 2020 4:07:53 pm An actor dressed as a coronavirus reacts after injecting a fantasy vaccine during a street performance in Plaza San Martín (AP) Encouraging results in Covid-19 vaccine trials by pioneers in November have …
Read More »The Pfizer Covid-19 vaccine is 90% effective. Will India get it?
Written by Prabha Raghavan, edited by Explained Desk | New Delhi | Updated: November 10, 2020 3:43:25 pm The company’s first interim efficacy analysis indicates that the vaccine may demonstrate efficacy against Covid-19. (Reuters) The American pharmaceutical company Pfizer has launched preliminary data from late-stage human trials of the Covid-19 …
Read More »Doctors, MBBS students among 30 million people who will receive the Covid-19 vaccine first, Aadhaar is not required
As Bharat Biotech aims to launch its vaccine, Covaxin, in February, which could be the first vaccine available in India, the Center is finalizing the procedure for administering the vaccine, including identifying the priority groups to target. they will administer the vaccine first and at no cost. . The group …
Read More »Vaccine ready for December, on the market for March: Serum Institute reveals Covid-19 vaccine planning
India will receive 60-70 million doses of the Covishield vaccine from Oxford by December, but the vaccines will hit the market in March 2021, the Serum Institute of India (SII) in Pune said, revealing its latest updates on the ongoing trial of the Astrazeneca-Oxford vaccine. Time between December and March …
Read More »